Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study

摘要

Background: Omalizumab, a humanized anti-IgE monoclonal antibody, is reportedly an effective treatment for severe allergic asthma. However, there have been few comprehensive analyses of its efficacy, including assessments of small airways or airway remodeling.